Navigation Links
The New York Stem Cell Foundation announces new initiative for Parkinson's disease
Date:6/22/2011

NEW YORK CITY (June 22, 2011)The New York Stem Cell Foundation (NYSCF) has received a half-million dollar gift from the Golub family to launch the NYCF-Golub Stem Cell Initiative for Parkinson's Disease. The initiative permits researchers in the NYSCF Laboratory to use a novel approach to understand Parkinson's disease that includes the creation of stem cell lines from a genetically diverse population of Parkinson's patients.

The announcement was made at the NYSCF Laboratory by the organization's CEO Susan L. Solomon, NYSCF Board Chairman Dr. Roy Geronemus, and Lawrence E. Golub, President of Golub Capital, and his wife Karen Finerman, President and CEO of Metropolitan Capital Advisors.

According to Ms. Solomon, the NYSCF Golub Initiative provides a remarkable opportunity to advance the search for better therapies for Parkinson's disease, and supports a dedicated team of Parkinson's researchers in the NYSCF Laboratory. The research will include creating stem cell lines from a genetically diverse population of Parkinson's patients, which will be part of a large bank of lines that will greatly accelerate the creating of new drugs and therapies on actual cells that are dying of the disease. It will permit NYSCF researchers and their collaborators to screen for drugs that slow or stop the progression of Parkinson's disease.

"We are so grateful to Lawrence Golub and Karen Finerman for their generous support of a new approach that holds so much promise for this debilitating disease that creates so much suffering for patients and their families," says Ms. Solomon. "This is an incredible opportunity to advance the search for better treatments for Parkinson's disease. The current therapies are just not acceptable."

"Our goal is to accelerate treatments and translational work that pharmaceutical companies are not prepared to do," said Mr. Golub, who explains the lines will be made available to qualified private and public sector scientists for research purposes. "NYSCF has the right people and the right lab to get the job done. Our goal is to create a drug-testing factory that turns raw science into drugs for the public sector."


'/>"/>

Contact: Nadine Woloshin
nwoloshin@rubenstein.com
212-843-8041
New York Stem Cell Foundation
Source:Eurekalert

Related medicine news :

1. Damon Runyon Cancer Research Foundation awards $3.45 million to 9 top young clinical investigators
2. SIR Foundation sets research priorities for minimally invasive treatments for MS patients
3. Lymphoma Research Foundation and John Theurer Cancer Center collaborate for Lymphoma Rounds program
4. Outstanding high school students receive AGA Research Foundation Fellowship Awards
5. The New York Stem Cell Foundation awards fellowships to 7 innovative stem cell scientists
6. MetLife Foundations grant bolsters media coverage for aging issues
7. John Theurer Cancer Center and the Promise Foundation partner to offer free skin cancer screenings
8. Cole Foundation injects $700,000 into childhood cancer research
9. Cedars-Sinais mobile medical clinics receive $500,000 grant from California Community Foundation
10. Gates Foundation awards Ben-Gurion U. researcher grant for malaria detection using cell phones
11. AACR and Landon Foundation support the next generation of researchers with INNOVATOR Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... , ... PurhealthRX , a leading Health and Nutrition Company, is announcing ... full spectrum CBD oil will revolutionize the rapidly growing CBD market by reducing the ... incorporated into liquid products, while reducing costs to end users. , The team of ...
(Date:10/13/2017)... ... ... The Visiting Nurse Association (VNA) of Somerset Hills is proud to host ... items from across the nation, this holiday-themed event will raise funds and awareness for ... The boutique will be open Saturday, November 4 (10:00 a.m. – 5:00 p.m.) ...
(Date:10/13/2017)... ... 13, 2017 , ... Coveros, a leader in agile coaching ... contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile ... of Agile methodologies in a consistent and high value manner across CMS programs. ...
(Date:10/12/2017)... New Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... fitness centers in the U.S., announced today its plans to open a flagship location ... club will occupy the former Rooms To Go store next to Office Depot in ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
Breaking Medicine News(10 mins):
(Date:9/22/2017)... 2017 AVACEN Medical (AVACEN) announced that its ... helping those with the widespread pain associated with fibromyalgia ... in Essex, England commented, "I ... experiencing no sleep at all, tremendous pain, with every ... recommend [the AVACEN 100] enough, how this has and ...
(Date:9/18/2017)... , Sept. 18, 2017 EpiVax, ... of bioinformatics and immune engineering, today announced ... influenza A (H7N9) vaccine. ... to seasonal influenza and presents a challenge ... prior exposure to be effective. Using state-of-the-art ...
(Date:9/12/2017)... 2017  ValGenesis Inc., the global leader in ... to announce the appointment of Dr. Ajaz ... of Directors and Chairman of Advisory Board beginning ... companies to manage their entire validation lifecycle process ... this process. Furthermore, ValGenesis VLMS enables rigorous compliance, ...
Breaking Medicine Technology: